Avance Clinical Brings 30 Years of Early-Phase and Therapeutic Leadership to European Biotechs at BIO-Europe 2026
Avance Clinical will exhibit at Booth #8-24 at BIO-Europe 2026. The event runs 9–11 November 2026 at Koelnmesse in Cologne, Germany.
Avance Clinical will exhibit at Booth #8-24 at BIO-Europe 2026. The event runs 9–11 November 2026 at Koelnmesse in Cologne, Germany.
Avance Clinical exhibits at K-INNO WEEK 2026 from November 18–20, Cheongju, Booth C116-2, to discuss first-in-human trials in Australia. Book a meeting.
Visit Avance Clinical at Stand #72, AusBiotech International Conference 2026, 21–23 October at the Gold Coast Convention and Exhibition Centre.
Avance Clinical and the Department of Food & Medical Products Regulatory Policy meet Korean biotechs at Seoul Global Forum 2026 on November 17 to discuss early-phase trials in Australia.
Avance Clinical, the global CRO for biotechs, attends BIO CHINA 2027 (March 10–12, Suzhou) to discuss a global development pathway. Book a meeting.
Discover how risk-based monitoring strategies like tSDV can improve early phase trial oversight without compromising data integrity.
Avance Clinical, Australia's early-phase CRO, exhibits at BIO-Europe 2026, Booth #8-24. FDA/EMA-accepted data and fast study start-up. Book a meeting.
Avance Clinical is exhibiting at AusBiotech International Conference 2026 on the Gold Coast.
Biotechs choose Avance Clinical when they need more than access to Australia – they need a CRO partner that can turn the Australian framework into a faster, more predictable early phase program.